Prenatal maternal antibiotic use increases the risk of childhood eczema: a systematic review and meta-analysis

Szilárd Petrás1, Bettina Vargáné Szabó1, Tivadar Kiss2

  • 1Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Szikra u. 6. Szeged, H-6725, Szeged, Hungary.

Scientific Reports
|May 8, 2026
PubMed

Insights

Maternal antibiotic use during pregnancy, particularly before birth, is linked to an increased risk of childhood atopic dermatitis. This finding suggests careful consideration of antibiotic prescriptions during pregnancy for infant health.

Area of Science:

  • Microbiome research
  • Developmental pediatrics
  • Pharmacology

Background:

  • Early-life microbiome disruption negatively impacts health.
  • The long-term effects of maternal medication use on the gut microbiota and offspring health are not fully understood.

Purpose of the Study:

  • To assess the association between maternal antibiotic use during pregnancy (prenatal or intrapartum) and the risk of childhood atopic dermatitis.
  • To synthesize evidence from existing cohort and case-control studies.

Main Methods:

  • A comprehensive meta-analysis was performed using data from EMBASE, PubMed, Cochrane, and Web of Science.
  • Included 30 studies encompassing over 4.1 million mothers and 4.3 million children.
  • Analyzed data using random effects models and adjusted for publication bias with the trim-and-fill method.

Main Results:

  • Prenatal antibiotic exposure was significantly associated with a higher risk of childhood atopic dermatitis (adjusted odds ratio: 1.32).
  • This association remained significant after adjusting for publication bias (adjusted odds ratio: 1.22).
  • Intrapartum antibiotic use did not show a significant association with increased risk of childhood atopic dermatitis (odds ratio: 1.64).

Conclusions:

  • Prenatal antibiotic use during pregnancy may have a modest but significant impact on the risk of developing atopic dermatitis in offspring.
  • Findings underscore the importance of evaluating antibiotic prescribing practices during pregnancy concerning long-term child health outcomes.
  • Further research may be warranted to explore mechanisms and clinical implications.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...